A.52 Zanubrutinib - chronic lymphocytic leukaemia/small lymphocytic lymphoma - EML
Application, expert reviews and public comments
Application
Expert reviews
Comments
WHO Department Comments
EML Working Groups
WHO Department Comments
EML Working Groups